SFX by Ex Libris Inc.

Title:	Genetics. First-class control of HIV-1
Source:	Science [0036-8075] McMichael, A J yr:2010

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Makadzange, Azure T. "Identification of a novel HLA B*57 restricted cytotoxic T-lymphocyte epitope within HIV-1 rev." AIDS 20.3 (2006): 462-464.
description	2.	Salgado, M. "An additive effect of protective host genetic factors correlates with HIV-non progression status." Journal of acquired immune deficiency syndromes 56.4 (2010): 300-305.
description	3.	Wagner, Lisa M A. "Antiretroviral treatment for HIV-infected infants exposed to nevirapine." JAMA (Chicago, Ill.) 304.23 (2010): 2589-90.
description	4.	Busch, Richard P. "Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection." AIDS 17.13 (2003): 1871-9.
description	5.	Cunningham, Paul R L. "Pathogenesis of macrophage tropic HIV-1." Current HIV research 3.1 (2004): 53-60.
description	6.	Gazzard, B. "Why does HIV infection progress to AIDS?" BMJ. British medical journal 315.7107 (1997): 523-523.
description	7.	Meyers, T. "Virologic failure among children taking lopinavir/ritonavir-containing first-line antiretroviral therapy in South Africa." The Pediatric infectious disease journal (2015): 175-9.
description	8.	Blankson, Joel N. "Unstimulated primary CD4+ T cells from HIV-1-positive elite suppressors are fully susceptible to HIV-1 entry and productive infection." Journal of virology 85.2 (2011): 979-986.
description	9.	Hurley, Bartosz H. "Membrane Budding." Cell 143.6 (2011): 875-887.
description	10.	liebertonline@liebertpub.com (Jeffrey A. Anderson, Jeffrey A. "Genotypic Susceptibility Scores and HIV Type 1 RNA Responses in Treatment-Experienced Subjects with HIV Type 1 Infection." AIDS research and human retroviruses 24.5 (2008): 685-694.
description	11.	Gray, L. "Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome." Virology 337.2 (2005): 384-98.
description	12.	M, S. "Gene expression profiling of the host response to HIV-1 B, C, or A/E infection in monocyte-derived dendritic cells." Virology 352.1 (2006): 86-99.
description	13.	Bihl, F. "Impact of HLA-B alleles, epitope binding affinity, functional avidity, and viral coinfection on the immunodominance of virus-specific CTL responses." The journal of immunology 176.7 (2006): 4094-4101.
description	14.	Suresh, P. "Chemokines and chemokine receptors in HIV infection: Role in pathogenesis and therapeutics." Journal of postgraduate medicine 52.3 (2006): 210-7.
description	15.	Sacktor, Ned C C. "The International HIV Dementia Scale: a new rapid screening test for HIV dementia." AIDS 19.13 (2005): 1367-74.
description	16.	Wilson, J D D. "Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection." AIDS 14.3: 225-233.
description	17.	Mbulaiteye, S M M. "Declining HIV-1 incidence and associated prevalence over 10 years in a rural population in south-west Uganda: a cohort study." The lancet 360.9326: 41-46.
description	18.	Landau, N R A. "Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection." Cell 86.3 (1996): 367-77.
description	19.	Busch, M P P. "Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors." Transfusion 35.2 (1995): 91-7.
description	20.	Wei, George M M. "Antibody neutralization and escape by HIV-1." Nature 422.6929 (2003): 307-312.